TRGM Stock Chart & Stats
$0.05
<$0.01(600.00%)
At close: 4:00 PM EDT
$0.05
<$0.01(600.00%)
Day’s Range― - ―
52-Week Range$0.05 - $0.05
Previous CloseN/A
Volume2.90K
Average Volume (3M)0.00
Market Cap
$211.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-51.32
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding30,186,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TRGM FAQ
What was Targeted Medical Pharma Inc’s price range in the past 12 months?
Targeted Medical Pharma Inc lowest stock price was $0.05 and its highest was $0.05 in the past 12 months.
What is Targeted Medical Pharma Inc’s market cap?
Targeted Medical Pharma Inc’s market cap is $211.00.
When is Targeted Medical Pharma Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Targeted Medical Pharma Inc’s earnings last quarter?
Currently, no data Available
Is Targeted Medical Pharma Inc overvalued?
According to Wall Street analysts Targeted Medical Pharma Inc’s price is currently Overvalued.
Does Targeted Medical Pharma Inc pay dividends?
Targeted Medical Pharma Inc does not currently pay dividends.
What is Targeted Medical Pharma Inc’s EPS estimate?
Targeted Medical Pharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Targeted Medical Pharma Inc have?
Targeted Medical Pharma Inc has 30,186,000 shares outstanding.
What happened to Targeted Medical Pharma Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Targeted Medical Pharma Inc?
Currently, no hedge funds are holding shares in TRGM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Targeted Medical Pharma Inc
Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company also provides a proprietary billing process and supporting software (PDRx) that facilitates physician dispensing; provides inventory control; and assists regulatory reporting. In addition, it offers billing and collection services relating to its products on behalf of dispensing physician clients to private insurance and workers’ compensation insurance. Targeted Medical Pharma, Inc. distributes its products through a network of distributors and an internal sales force that sells products directly to dispensing physician clients. The company was formerly known as Targeted Medical Foods and changed its name to Targeted Medical Pharma, Inc. in 2006. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California.
Technical Analysis
China Pharma Holdings
―
―
Aytu BioScience
―
PainReform
―
Shuttle Pharmaceuticals Holdings, Inc.
―